Scientific exchange with HCPs and experts
Check below to see if you have what is needed for this opportunity, and if so, make an application asap.
Engage in peer‑to‑peer, compliant scientific discussions with KOLs and HCPs (e.g., allergists, ENT, pulmonologists, pediatricians, GPs) on disease state, clinical evidence, guidelines, and appropriate use of ALK therapies.
Deliver non‑promotional scientific presentations (1:1 and group) at meetings, clinical sessions, and educational events.
Support scientific advisory boards and educational initiatives to inform clinical evidence needs and advance best practice in patient care.
Systematically capture, synthesize, and share field insights (HCPs, reimbursement stakeholders, hospital committees)
Use approved materials; document field interactions and insights in approved systems (Veeva).
Monitor and communicate scientific developments, competitor clinical evidence, and guideline updates relevant to ALK’s therapeutic areas.
Map and cultivate scientific relationships with reimbursement and access stakeholders, including INAMI/RIZIV, mutualities/sickness funds, and hospital formulary/P&T committees; engage competent authorities (e.g., AFMPS) for scientific exchange as appropriate, in line with Medical governance and local codes.
Communicate unbiased, evidence‑based clinical value messages derived from the Global/Local Value Dossier, tailored to the needs of payer and access stakeholders.
Respond to scientific queries from reimbursement stakeholders and coordinate timely, compliant follow‑up with internal Medical and Market Access colleagues.
Value dossier and scientific support
Contribute to the local adaptation of the Global Value Dossier for Belgium: ensure the clinical narrative, comparators, endpoints, epidemiology, and care pathways reflect local practice and expectations.
Curate, review, and align local clinical literature and guideline updates to support value messaging and access materials under Medical governance.
Support development of scientific briefing documents and FAQs for use in compliant engagements with access stakeholders; ensure consistency and accuracy across materials.
Education:
Advanced degree in life sciences (PhD, MD, PharmD, MSc) required.
Experience
: Prior MSL/Medical Affairs experience in pharma/biotech strongly preferred; experience engaging with reimbursement stakeholders in Belgium is a plus.
Scientific/clinical
: Strong ability to interpret and communicate clinical evidence; familiarity with immunology/allergy/respiratory is advantageous.
Communication
: Excellent scientific communication and presentation skills; ability to translate complex clinical evidence into clear, balanced, stakeholder‑appropriate scientific messages.
Project management
: Proven ability to manage cross‑functional projects with multiple stakeholders and timelines.
Languages
: Fluency in French and English required; proficiency in Dutch preferred (role is Wallonia‑focused but national stakeholder interactions often require Dutch/English). xphnsxz
Other
: Valid driver’s license; willingness to travel 60–70% within Wallonia and to Brussels for national engagements.
Location:
Belgium (field-based, Wallonia; regular travel to Brussels for national stakeholders)
#J-18808-Ljbffr